
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285i-1]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
                    subpart 9--national eye institute
 
Sec. 285i-1. Clinical research on eye care and diabetes


(a) Program of grants

    The Director of the Institute, in consultation with the advisory 
council for the Institute, may award research grants to one or more 
Diabetes Eye Research Institutions for the support of programs in 
clinical or health services aimed at--
        (1) providing comprehensive eye care services for people with 
    diabetes, including a full complement of preventive, diagnostic and 
    treatment procedures;
        (2) developing new and improved techniques of patient care 
    through basic and clinical research;
        (3) assisting in translation of the latest research advances 
    into clinical practice; and
        (4) expanding the knowledge of the eye and diabetes through 
    further research.

(b) Use of funds

    Amounts received under a grant awarded under this section shall be 
used for the following:
        (1) Establishing the biochemical, cellular, and genetic 
    mechanisms associated with diabetic eye disease and the earlier 
    detection of pending eye abnormalities. The focus of work under this 
    paragraph shall require that ophthalmologists have training in the 
    most up-to-date molecular and cell biological methods.
        (2) Establishing new frontiers in technology, such as video-
    based diagnostic and research resources, to--
            (A) provide improved patient care;
            (B) provide for the evaluation of retinal physiology and its 
        affect on diabetes; and
            (C) provide for the assessment of risks for the development 
        and progression of diabetic eye disease and a more immediate 
        evaluation of various therapies aimed at preventing diabetic eye 
        disease.

    Such technologies shall be designed to permit evaluations to be 
    performed both in humans and in animal models.
        (3) The translation of the results of vision research into the 
    improved care of patients with diabetic eye disease. Such 
    translation shall require the application of institutional resources 
    that encompass patient care, clinical research and basic laboratory 
    research.
        (4) The conduct of research concerning the outcomes of eye care 
    treatments and eye health education programs as they relate to 
    patients with diabetic eye disease, including the evaluation of 
    regional approaches to such research.

(c) Authorized expenditures

    The purposes for which a grant under subsection (a) of this section 
may be expended include equipment for the research described in such 
subsection.

(July 1, 1944, ch. 373, title IV, Sec. 456, as added Pub. L. 103-43, 
title XI, Sec. 1101(a), June 10, 1993, 107 Stat. 168.)

                  Section Referred to in Other Sections

    This section is referred to in section 285i of this title.
